In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.
Feng X, Yang C, Huang Y, Su D, Wang C, Wilson LL, Yin L, Tang M, Li S, Chen Z, Zhu D, Wang S, Zhang S, Zhang J, Zhang H, Nie L, Huang M, Park JI, Hart T, Jiang D, Jiang K, Chen J.
Feng X, et al. Among authors: yin l.
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2406325121. doi: 10.1073/pnas.2406325121. Epub 2024 Sep 19.
Proc Natl Acad Sci U S A. 2024.
PMID: 39298484